Evidence map›Paper›PMID 33553794›Full record

ArticleHealth psychology research2020

Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2).

Gaetano Bertino, Rosalia Ragusa, Liberato Simone Corsaro, Evelise Frazzetto, Vincenzo Messina, Lucio Inguscio, Carlo Lai, Marilena Maglia, Andrea Nunnari, Pasquale Caponnetto

Open access · goldAbstract read
In one paragraph

Article in Health psychology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Gaetano BertinoHepatology Unit, Policlinic "G. Rodolico", Department of Clinical and Experimental Medicine, University of Catania.
Rosalia RagusaHealth Technology Assessment Committee, University Hospital "G. Rodolico", Catania.
Liberato Simone CorsaroBiologist, Master of Science in Clinical Trial Governance, University of Catania.
Evelise FrazzettoHepatology Unit, Policlinic "G. Rodolico", Department of Clinical and Experimental Medicine, University of Catania.
Vincenzo MessinaInfectious Disease Unit, Azienda Ospedaliera "S. Anna e S. Sebastiano" of Caserta.
Lucio InguscioDepartment of Dynamic and Clinical Psychology, University of Rome La Sapienza, Rome.
Carlo LaiDepartment of Dynamic and Clinical Psychology, University of Rome La Sapienza, Rome.
Marilena MagliaCenter of Excellence for the Acceleration of Harm Reduction (CoEHAR), Department of Clinical and Experimental Medicine, University of Catania.
Andrea NunnariSchool of Medicine, Course of Rehabilitation Science for Health Professions, Università di Catania, Italy.
Pasquale CaponnettoCenter of Excellence for the Acceleration of Harm Reduction (CoEHAR), Department of Clinical and Experimental Medicine, University of Catania.
University of Catania · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HCV (Hepatitis C Virus) decreases Health-Related Quality of Life with detriments to physical, mental and social health domains. Interferon and Ribavirin treatment is associated with depression and anxiety that further impairs HRQoL (Health- Related Quality of Life). IFN-free (interferon-free) regimes (Direct Acting Antivirals, DAAs) are safe and highly effective drugs, with improvement also of HRQoL and related Psychological Well-Being. Our aim is to describe how the latest generation IFN-free treatment can change quality of life and related Psychological Well-Being in Italian Chronic Hepatitis C/Cirrhosis affected patients. SF-36v2 (Short Form Health Survey is a 36-item, patient-reported survey of patient health) - HQLQv2 (Hepatitis Quality of Life Questionnaire) was administered at two time points: baseline (n=72) and 12 weeks after the end of therapy [n=72, SVR=72 - Sustained Virologic Response (SVR)]. Patients with chronic HCV undergoing DAAs treatment from two Italian centers were enrolled. The overall average of the answers is configured for most of the domains that make up the questionnaire, with scores above 50. The quality of life of this sample is very close to the average of the US population, with a minimum average score of 45.9 for the Role Emotional scale and an average maximum score of 56.4 for the Vitality scale. Both are significant results from statistical analysis. It seems that DAAs treatment therapy does not affect but improves the general quality and psychological state of adult patients with Chronic HCV infection.

Indexed as

chronic illnessHealth carehealth psychologyillness perceptionphycological wellbeingQoL

Identifiers

PMID33553794
PMCPMC7859961
OpenAlexW3123758983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.